Renalytix Plc Profit Margin

Renalytix Plc (RNLX) currently reports a profit margin of -190.01% as of March 2026. That compares with -1336.63% in the prior-year period — up 85.8% year over year. That is below the Healthcare sector average of 14.34%. Use the charts on this page to explore Renalytix Plc's profit margin history and peer comparisons.

Renalytix Plc's profit margin increased from -1336.63% to -190.01% — a 85.8% year-over-year increase (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Renalytix Plc's profit margin of -190.01% is lower than the Healthcare sector average of 14.34%. That is roughly 1424.6% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' profit margin, but Renalytix Plc's current -190.01% should be judged against Healthcare norms (sector average: 14.34%) and against RNLX's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current profit margin of -190.01%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 14.34%. From there, open related valuation or income-statement pages for Renalytix Plc, and consider following RNLX for alerts when major investors trade the stock.